Increased Protein Breakdown [PE] - N0000009531

Pharmacologic Class Information

Pharmacologic Code N0000009531
Pharmacologic Name Increased Protein Breakdown
Pharmacologic Uses
  • transthyretin-directed antisense oligonucleotide
  • transthyretin-directed small interfering RNA
Pharmacologic Concept Physiologic Effects - [PE]
Pharmacologic Concept Description This concept refers to the tissue, organ, or organ system effects of drug generic ingredients, organized into an organ system classification hierarchy, beneath the "Physiological Effects [PE]" concept.

NDC Products with Increased Protein Breakdown

The table contains 3 products whose active ingredient are classified under the same pharmacologic class Increased Protein Breakdown [PE].

NDC Proprietary Name Non-Proprietary Name Dosage Form Route Name Company Name Status
71336-1000Onpattro Non-Proprietary Name: PatisiranInjection, Lipid ComplexIntravenousAlnylam Pharmaceuticals, Inc.ACTIVE
71336-1003Amvuttra Non-Proprietary Name: VutrisiranInjectionSubcutaneousAlnylam Pharmaceuticals, Inc.ACTIVE
72126-007Tegsedi Non-Proprietary Name: InotersenInjection, SolutionSubcutaneousAkcea Therapeutics, Inc.ACTIVE